Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Delivering Palliative Care by Telehealth Meets the Needs of People with...

Ogkologos - 28 Οκτωβρίου, 2024

FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole...

Ogkologos - 28 Οκτωβρίου, 2024

Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic...

Ogkologos - 25 Οκτωβρίου, 2024

Program Connects Adolescents and Young Adults to Quality Cancer Care

Ogkologos - 24 Οκτωβρίου, 2024

Women Diagnosed with Early Breast Cancer Since 2000 Have About a...

Ogkologos - 24 Οκτωβρίου, 2024

Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board,...

Ogkologos - 18 Οκτωβρίου, 2024

Will Ponsegromab Be a Game Changer for Cancer Cachexia?

Ogkologos - 17 Οκτωβρίου, 2024

Trastuzumab Deruxtecan Prolongs PFS After Endocrine-Based Therapy in Patients with HR-positive,...

Ogkologos - 17 Οκτωβρίου, 2024

As More People with Cancer Use Medical Cannabis, Oncologists Face Questions...

Ogkologos - 16 Οκτωβρίου, 2024

Insights Into the Biology of Response and Resistance to MAPK Pathway...

Ogkologos - 16 Οκτωβρίου, 2024

1...666768...440 Σελίδα 67 από 440

MOST POPULAR

Common anti-inflammatory drug could boost cancer immunotherapy

26 Μαΐου, 2021

April is Occupational Therapy (OT) Month- What is OT and how...

8 Απριλίου, 2021

Workout Wednesdays – Leg Exercises Part 3

24 Ιουνίου, 2020

EMA Issues Direct Healthcare Professional Communications for Crizotinib-Related Vision Disorders in...

24 Ιουνίου, 2022

Φόρτωση περισσοτέρων

Delivering Palliative Care by Telehealth Meets the Needs of People with...

FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole...

Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic...

Program Connects Adolescents and Young Adults to Quality Cancer Care

Women Diagnosed with Early Breast Cancer Since 2000 Have About a...

Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board,...

Will Ponsegromab Be a Game Changer for Cancer Cachexia?

Trastuzumab Deruxtecan Prolongs PFS After Endocrine-Based Therapy in Patients with HR-positive,...

As More People with Cancer Use Medical Cannabis, Oncologists Face Questions...

Insights Into the Biology of Response and Resistance to MAPK Pathway...

MOST POPULAR

Common anti-inflammatory drug could boost cancer immunotherapy

April is Occupational Therapy (OT) Month- What is OT and how...

Workout Wednesdays – Leg Exercises Part 3

EMA Issues Direct Healthcare Professional Communications for Crizotinib-Related Vision Disorders in...

HOT NEWS

Pembrolizumab Demonstrates Robust, Durable Antitumour Activity and Promising Survival in Advanced...

Dad Creates Inclusive Children’s Book For Daughter With Disability And Others...

Olivia Newton-John Puts On Iconic ‘Grease’ Costume And Talks About Cancer...

Immunoscore Classification Significantly Associates with Time to Recurrance In Asian Patients...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ